News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Deals
International Drug & Explosives Detection Firm IDenta Corporation Issues New Statement Concerning Buy-Out Discussions With U.S. Corporation
June 28, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
JERUSALEM, ISRAEL--(MARKET WIRE)--Jun 28, 2007 -- The CEO of IDenta Corp. (Other OTC:IDTA.PK - News) issued a statement today that provides some additional information on Tuesday's official statement concerning recent buy-out and merger offers.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Asia
MORE ON THIS TOPIC
Lung cancer
Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial—again
September 3, 2026
·
2 min read
·
Annalee Armstrong
Deals
GSK inks another Asia alliance, betting up to $1.3B for HUTCHMED’s cancer therapy
September 3, 2026
·
1 min read
·
Tristan Manalac
Cancer
Roche finds another oncology gem in Asia with $1.5B B cell disease partnership
September 1, 2026
·
2 min read
·
Annalee Armstrong
Mergers & acquisitions
Deal-hungry Lilly strikes up to $2.9B immuno play for Merida
August 31, 2026
·
2 min read
·
Tristan Manalac